Please use this identifier to cite or link to this item:
|Title:||SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.|
Scottish Gynaecological Cancer Trials Group
Beatson West of Scotland Cancer Centre
|Citation:||GYNECOL ONCOL, 2011, 123 (1), pp. 105-109|
|Abstract:||The aim of the study was to determine the response rate and response duration of cervical cancer previously treated by cisplatin (with or without radiation) to a combination of docetaxel and gemcitabine. Secondary endpoints were assessment of toxicity and quality of life (QoL) of patients receiving the treatment.|
|Appears in Collections:||Published Articles, Dept. of Cancer Studies and Molecular Medicine|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.